FDA Approves Drug for Shizophrenia and Bi-Polar Disorder
By Rachel Stockton A drug that has just been approved by the FDA to treat schizophrenia and bipolar 1 disorder will hit the US market in the 4th quarter of this year. Saphis is manufactured by Shering-Plough, a pharmaceutical company planning on a merger with Merck in the upcoming weeks. While the FDA endorses the [...]
